TEMPUS NEXT
Live / Applied — Statement of use — registration review complete (as of 28 Mar 2026)
What this means for you
Not registered yet, but its 15 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98976105
- Mark type
- Stylized text
- Filed
- 15 Sept 2023
- Published for opposition
- 23 Jan 2024
- Attorney of record
- Jeremy D. Bisdorf
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring online non-downloadable software for use in providing recommendations for patient treatment and care in the fields of oncology and neurology; software as a service (SAAS) services featuring software using artificial intelligence for machine learning and predictive analytics to support clinical data platforms for patient diagnosis and treatment in the fields oncology and neurology
- Class 044 — Medical, beauty and agricultural services: Medical services; providing medical information in the fields of oncology and neurology
Owner
- Tempus Labs, Inc., Chicago, IL, US
- Tempus Labs, Inc., Chicago, IL, US
Prosecution history
- 28 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Mar 2026 — ASSIGNED TO LIE
- 18 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Dec 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 22 Dec 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 20 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Sept 2025 — NON-FINAL ACTION E-MAILED
- 20 Sept 2025 — SU - NON-FINAL ACTION - WRITTEN
- 17 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Feb 2025 — USE AMENDMENT FILED
- 18 Jun 2025 — DIVISIONAL PROCESSING COMPLETE
- 20 Feb 2025 — DIVISIONAL REQUEST RECEIVED